IVF for Endometriosis — Protocol Adaptations and Outcomes

IVF in patients with endometriosis requires protocol adaptation, careful surgery-versus-IVF-first decisions, and honest counselling about outcomes. This page covers how IVF is modified for endometriosis patients and what realistic outcomes to expect.

1. Surgery-versus-IVF-first decision

ESHRE 2022 framework guides this critical decision. Asymptomatic small endometrioma in patient ready for IVF — IVF first often preferred (avoid ovarian reserve damage). Symptomatic large endometrioma — surgery first. Hydrosalpinx — always address before IVF. Deep infiltrating disease without anatomic correction needs — IVF first. Individualised assessment essential.

2. Protocol selection

Long agonist protocol historically favoured for endometriosis — better disease suppression during stimulation, some studies show improved implantation. Antagonist protocol acceptable for most. Ultra-long agonist (2–3 months) for severe disease with high activity. Decision based on disease severity, ovarian reserve, time constraints.

3. Ovarian reserve considerations

Endometriosis can reduce ovarian reserve, especially with endometriomas. AMH baseline essential before IVF. Bilateral endometriomas more concerning than unilateral. Previous ovarian surgery compounds reserve impact. Mild stimulation or adapted protocols for low-reserve endometriosis patients.

4. Endometrioma management before IVF

Generally — do not operate on asymptomatic small endometriomas in IVF-ready patients. ESHRE 2022 supports this approach. Surgical removal reduces ovarian reserve. Large endometriomas (over 5 cm), suspicion of malignancy, or significant symptoms may warrant pre-IVF surgery. Each case individualised.

5. Adenomyosis considerations

Adenomyosis coexists with endometriosis in 30–80 percent of moderate-severe cases. Adenomyosis reduces implantation rates and increases miscarriage. Pre-transfer GnRH suppression often used. Frozen embryo transfer after disease suppression may improve outcomes. Severe adenomyosis sometimes needs medical optimisation before any transfer.

6. Freeze-all strategy

Increasingly used in endometriosis IVF. Allows disease suppression after stimulation before transfer. Optimised endometrial preparation in subsequent cycle. Reduces inflammatory exposure during early pregnancy. Particularly valuable in adenomyosis. Outcomes comparable to or better than fresh transfer.

7. Realistic outcome expectations

Per-cycle pregnancy rates with endometriosis are slightly lower than non-endometriosis IVF (perhaps 5–10 percentage points). Cumulative success across multiple cycles approaches non-endometriosis rates. Severe stage III–IV disease may have more significant impact. Age remains the dominant factor — endometriosis adds incremental impact.

8. Pre-IVF optimisation

3-month lifestyle optimisation. Vitamin D correction. Anti-inflammatory dietary pattern. Smoking cessation (smoking and endometriosis compound impact). Weight optimisation. Disease optimisation (hormonal suppression often paused 1–2 months before stimulation). Mental health support. Partner sperm DNA fragmentation evaluation if recurrent failures.

Frequently Asked Questions

Related endometriosis reading

Dr. Priyadatt Patel

Senior Gynecologist · Advanced Laparoscopic Surgeon · IVF and Endometriosis Programme Lead

MS OBGyn · Pregnancy Care · Advanced Gynaecological Ultrasound · Fertility Preservation

ESHRE / ESGE / AAGL / ASRM guideline-aligned practice. 3D Karl Storz precision technique. Fertility-preservation-first philosophy. Evidence-based decisions, honest counselling, long-term outcomes orientation.